{
  "symbol": "CRL",
  "name": "Charles River Laboratories",
  "sector": "Health Care",
  "industry": "Life Sciences Tools & Services",
  "date_added": "2021-05-14",
  "headquarters": "Wilmington, Massachusetts",
  "founded": "1947",
  "market_cap": 7706.499072,
  "pe_ratio": null,
  "forward_pe": 15.263133,
  "eps": -0.62,
  "revenue": 4022.59712,
  "profit_margin": -0.00489,
  "debt_to_equity": 92.213,
  "return_on_equity": -0.00671,
  "dividend_yield": null,
  "current_price": 156.90499877929688,
  "year_high": 254.14999389648438,
  "year_low": 91.86000061035156,
  "price_change_1d": -0.9375595783029055,
  "price_change_1w": 1.6224125530030462,
  "price_change_1m": 11.122522783631123,
  "description": "Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic se",
  "website": "https://www.criver.com",
  "employees": 18700,
  "exchange": "NYQ",
  "currency": "USD",
  "analyst_target_price": 156.14175,
  "recommendation": 2.68421,
  "number_of_analysts": 17,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 200.0,
    "target_low": 70.0,
    "target_mean": 156.14175,
    "target_median": 155.0
  },
  "last_updated": "2025-07-09T11:18:47.500665",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}